TrialClinical pharmacokinetics2024

Intra-individual Dose Escalation of Abiraterone According to Its Plasma Exposure in Patients with Progressive Metastatic Castration-Resistant Prostate Cancer: Results of the OPTIMABI Trial.

Jérôme Alexandre et al.PubMed ↗Publisher ↗

No numbers read from the abstract.